Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GH | JAZZ | EXEL | ||
| Company | Guardant Health Inc | Jazz Pharma Plc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 86.33 | 184.96 | 41.57 | ||
| High | 87.21 | 185.02 | 41.57 | ||
| Low | 82.26 | 179.03 | 40.51 | ||
| Latest | 84.02 | 180.32 | 41.17 | ||
| Change | -4.01 | -5.11 | -0.58 | ||
| % Change | -4.56% | -2.76% | -1.39% | ||
| Volume | 3,016,100 | 831,400 | 2,785,200 | ||
| 20-Day Average Volume | 1,957,275 | 1,133,945 | 3,232,135 | ||
| Previous Close | 88.03 | 185.43 | 41.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 96.23 | 180.13 | 42.90 | ||
| 20-Day Raw Stochastic | 5.58% | 46.29% | 23.70% | ||
| 20-Day Relative Strength | 31.88 | 54.17 | 43.43 | ||
| Weighted Alpha | +53.67 | +38.48 | +4.90 | ||
| Today's Opinion | 8% Sell | 100% Buy | 8% Sell | ||
| Previous Opinion | 8% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 56% Buy | 40% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.25% since 03/05/26 | -1.80% since 03/05/26 | -0.27% since 03/05/26 | ||
| Low | 82.26 on 03/12/26 | 176.67 on 03/06/26 | 40.24 on 03/06/26 | ||
| High | 93.00 on 03/06/26 | 188.62 on 03/10/26 | 42.67 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | -18.24% since 02/12/26 | +8.44% since 02/12/26 | -3.58% since 02/12/26 | ||
| Low | 82.26 on 03/12/26 | 165.36 on 02/17/26 | 39.71 on 03/02/26 | ||
| High | 113.78 on 02/20/26 | 198.00 on 02/26/26 | 45.87 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | -17.68% since 12/12/25 | +7.65% since 12/12/25 | +0.71% since 12/12/25 | ||
| Low | 82.26 on 03/12/26 | 156.95 on 01/08/26 | 39.71 on 03/02/26 | ||
| High | 120.74 on 01/22/26 | 198.00 on 02/26/26 | 47.24 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +53.06% since 09/12/25 | +42.93% since 09/12/25 | +5.16% since 09/12/25 | ||
| Low | 53.40 on 09/16/25 | 123.88 on 09/15/25 | 33.76 on 10/20/25 | ||
| High | 120.74 on 01/22/26 | 198.00 on 02/26/26 | 47.24 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,020,901 | 11,100,500 | 10,692,220 | ||
| Shares Outstanding, K | 131,170 | 61,560 | 259,709 | ||
| Annual Sales | 982,020,000 | 4,267,590,000 | 2,320,130,000 | ||
| Annual Net Income | -416,280,000 | -356,150,000 | 782,570,000 | ||
| Last Quarter Sales | 281,270,000 | 1,197,930,000 | 598,660,000 | ||
| Last Quarter Net Income | -128,490,000 | 203,450,000 | 244,530,000 | ||
| 60-Month Beta | 1.67 | 0.22 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 02/19/26 | 6.64 on 02/24/26 | 0.94 on 02/10/26 | ||
| Latest Earnings Date | 04/29/26 | 05/05/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 43.32 | 15.29 | ||